Skip to content
Riskpilot
← Back to search
Sign in
Get full access
IMB Jutland ApS
APS
Active
CVR 38031171
Nygade 11, 6580
Vamdrup
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2016 · 9 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
IMB Jutland ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-3
-5
-5
-6
-4
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-3
-5
-5
-6
-4
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-3
-5
-5
-6
-4
Net financials
8
-0
5
277
-275
Profit before tax
5
-5
-0
272
-279
Tax
3
-0
0
-0
-0
Net profit
2
-5
-0
272
-279
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
254
254
256
534
259
Equity
235
230
230
501
222
Long-term debt
0
0
0
0
0
Short-term debt
19
24
27
32
36
Total debt
19
24
27
32
36
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-400000.0%
This company
2021
2025
Equity ratio
85.9%
This company
38.2%
Market median
+125% vs market
2021
2025
Return on equity
-125.5%
This company
18.4%
Market median
-782% vs market
2021
2025
Net profit margin (of gross profit)
-27900100.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.02×
This company
2021
2025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on IMB Jutland ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
